HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fadi Fakhouri Selected Research

Neoplasms (Cancer)

1/2022ANCA-Negative Pauci-immune Necrotizing Glomerulonephritis: A Case Series and a New Clinical Classification.
1/2019Atypical and secondary hemolytic uremic syndromes have a distinct presentation and no common genetic risk factors.
1/2019Etiology and Outcomes of Thrombotic Microangiopathies.
8/2017Haemolytic uraemic syndrome.
4/2007Prognostic value of anti-ADAMTS 13 antibody features (Ig isotype, titer, and inhibitory effect) in a cohort of 35 adult French patients undergoing a first episode of thrombotic microangiopathy with undetectable ADAMTS 13 activity.
7/2005ANCA-negative pauci-immune renal vasculitis: histology and outcome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Fadi Fakhouri Research Topics

Disease

24Thrombotic Microangiopathies
02/2024 - 06/2005
23Atypical Hemolytic Uremic Syndrome
02/2024 - 12/2008
16Glomerulonephritis
06/2023 - 02/2002
12Hemolytic-Uremic Syndrome
02/2024 - 12/2007
9Kidney Diseases (Kidney Disease)
02/2024 - 09/2008
9Chronic Kidney Failure (Chronic Renal Failure)
01/2022 - 08/2003
8Infections
07/2023 - 07/2005
7Renal Insufficiency (Renal Failure)
02/2024 - 08/2003
7Vasculitis (Vasculitides)
01/2022 - 07/2005
7Thrombotic Thrombocytopenic Purpura
11/2020 - 02/2004
6Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II)
01/2022 - 09/2008
6Neoplasms (Cancer)
01/2022 - 07/2005
6Lipoid Nephrosis (Glomerulonephritis, Minimal Change)
03/2021 - 06/2005
6Nephrotic Syndrome (Syndrome, Nephrotic)
01/2018 - 06/2005
5Inflammation (Inflammations)
01/2022 - 08/2010
5Chronic Renal Insufficiency
01/2021 - 08/2003
5Hemolysis
11/2020 - 12/2008
5Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
03/2020 - 08/2007
5Proteinuria
01/2018 - 08/2003
4Meningococcal Infections
07/2023 - 01/2016
4Hypertension (High Blood Pressure)
09/2021 - 08/2003
4Membranous Glomerulonephritis (Membranous Nephropathy)
03/2021 - 06/2005
4Pre-Eclampsia (Preeclampsia)
11/2020 - 05/2010
4Thrombosis (Thrombus)
01/2019 - 01/2011
4Fibrosis (Cirrhosis)
01/2018 - 01/2002
3Interstitial Nephritis (Tubulointerstitial Nephritis)
03/2021 - 08/2003
3Malignant Hypertension
01/2021 - 01/2019
3Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
11/2020 - 06/2003
3Eclampsia
11/2020 - 12/2012
3Lupus Nephritis
01/2017 - 08/2008
3Acute Kidney Injury (Acute Renal Failure)
01/2014 - 04/2009
3Fanconi Syndrome (Syndrome, Fanconi)
08/2010 - 09/2005
3Multiple Myeloma
06/2009 - 04/2004
2Systemic Scleroderma (Systemic Sclerosis)
02/2024 - 01/2011
2Hematologic Neoplasms (Hematological Malignancy)
02/2024 - 07/2011
2Ischemia
11/2023 - 10/2013
2Inborn Genetic Diseases (Disease, Hereditary)
06/2023 - 01/2022
2Hypoxia (Hypoxemia)
03/2022 - 01/2016
2COVID-19
11/2021 - 01/2020
2IGA Glomerulonephritis (IGA Nephropathy)
03/2021 - 05/2009
2Autoimmune Diseases (Autoimmune Disease)
01/2019 - 01/2019
2Necrosis
01/2011 - 09/2008
2Pregnancy Complications
05/2010 - 06/2003
2Amyloidosis
09/2008 - 03/2008
2Kidney Cortex Necrosis
07/2005 - 05/2005
1Bacterial Infections (Bacterial Infection)
02/2024
1Brain Death (Brain Dead)
11/2023
1Anemia
03/2022
1Renal Cell Carcinoma (Grawitz Tumor)
01/2022
1Hypocalcemia
01/2022
1Primary Hyperoxaluria (Oxaluria, Primary)
11/2021
1Hyperoxaluria (Oxaluria)
11/2021

Drug/Important Bio-Agent (IBA)

35Complement System Proteins (Complement)IBA
02/2024 - 03/2007
16eculizumabFDA Link
01/2022 - 12/2012
12Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
01/2022 - 06/2005
8AntibodiesIBA
03/2020 - 09/2005
8Rituximab (Mabthera)FDA Link
01/2019 - 02/2004
6EnzymesIBA
11/2021 - 09/2005
6Immunoglobulin G (IgG)IBA
03/2020 - 02/2002
6SteroidsIBA
01/2018 - 03/2003
6CreatinineIBA
01/2018 - 08/2003
5Shiga Toxin (Shigella Toxin)IBA
02/2024 - 08/2017
5Complement Inactivating AgentsIBA
06/2022 - 04/2016
5thiamine triphosphorate (TTP)IBA
11/2020 - 08/2005
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2024 - 02/2009
4Complement Factor H (Factor H)IBA
01/2018 - 03/2007
3Immunoglobulins (Immunoglobulin)IBA
01/2022 - 03/2020
3Adrenal Cortex Hormones (Corticosteroids)IBA
01/2020 - 03/2009
3Immunosuppressive Agents (Immunosuppressants)IBA
01/2019 - 11/2009
2Transcription Factors (Transcription Factor)IBA
03/2022 - 05/2007
2Complement C3 (C3 Complement)IBA
01/2022 - 01/2019
2AutoantibodiesIBA
01/2022 - 03/2020
2Hemoglobins (Hemoglobin)IBA
01/2021 - 12/2019
2Peroxidase (Myeloperoxidase)IBA
03/2020 - 01/2012
2Membrane Cofactor ProteinIBA
01/2018 - 12/2008
2Anti-Bacterial Agents (Antibiotics)IBA
01/2010 - 07/2009
2AA amyloidosisIBA
05/2009 - 03/2008
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
03/2009 - 02/2004
2Fibrinogen (Factor I)FDA Link
12/2008 - 03/2007
2Immunoglobulin M (IgM)IBA
09/2008 - 03/2008
1GemcitabineFDA Link
02/2024
1Complement Factor I (C3b Inactivator)IBA
02/2024
1Complement Factor B (Factor B)IBA
07/2023
1IronIBA
03/2022
1ErythropoietinFDA Link
03/2022
1factor AIBA
03/2022
1MicroRNAs (MicroRNA)IBA
01/2022
1MagnesiumIBA
01/2022
1Messenger RNA (mRNA)IBA
01/2022
1claudin 16IBA
01/2022
1OxalatesIBA
11/2021

Therapy/Procedure

17Therapeutics
02/2024 - 08/2003
7Kidney Transplantation
02/2024 - 11/2011
7Transplantation
01/2022 - 04/2007
3Renal Dialysis (Hemodialysis)
04/2021 - 01/2014
3Plasma Exchange
01/2018 - 04/2009
2Aftercare (After-Treatment)
03/2015 - 05/2005
2Stem Cell Transplantation
06/2009 - 05/2007
1Intravenous Administration
07/2023
1Renal Replacement Therapy (Therapies, Renal Replacement)
06/2023